Skip to content
2000
Volume 20, Issue 4
  • ISSN: 1574-8871
  • E-ISSN: 1876-1038

Abstract

Introduction/Objective

Significant advancements have been achieved with the use of targeted molecular therapies for the treatment of Soft Tissue Sarcomas (STS). However, data remain scarce about the potential benefits and toxicity of this therapeutic option. In this narrative review, we aim to better clarify the potential wound healing complications in STS patients undergoing neoadjuvant (NA) radiotherapy (RT) combined with targeted therapies.

Methods

We used the PubMed database to retrieve journal articles, and the inclusion criteria were all studies that illustrated the potential RT toxicity, combined with targeted therapies, in the NA setting of STS patients.

Results

Our search resulted in seven studies that fulfilled the inclusion criteria. Delayed wound complication rates were observed similarly to RT alone, while one study reported intolerable toxicity without referring specifically to wound complications.

Conclusion

The combination of RT with targeted therapies in STS seems to be effective and well tolerated. Due to the lack of studies with a high level of evidence, further research is required to enhance the existing knowledge for its potential value in this field.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/rrct/10.2174/0115748871354960250315170817
2025-05-07
2025-12-17

  • From This Site

    /content/journals/rrct/10.2174/0115748871354960250315170817
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MastrangeloG. CoindreJ.M. DucimetièreF. Dei TosA.P. FaddaE. BlayJ.Y. BujaA. FedeliU. CegolonL. FrassonA. Ranchère-VinceD. MontescoC. Ray-CoquardI. RossiC.R. Incidence of soft tissue sarcoma and beyond.Cancer2012118215339534810.1002/cncr.2755522517534
     [Google Scholar]
  2. TiongS.S. DickieC. HaasR.L. O’SullivanB. The role of radiotherapy in the management of localized soft tissue sarcomas.Cancer Biol. Med.201613337338310.20892/j.issn.2095‑3941.2016.002827807504
     [Google Scholar]
  3. CanterR.J. MartinezS.R. TamurianR.M. WiltonM. LiC.S. RyuJ. MakW. MonskyW.L. BorysD. Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma.Ann. Surg. Oncol.201017102578258410.1245/s10434‑010‑1156‑320556523
     [Google Scholar]
  4. WeitzJ. AntonescuC.R. BrennanM.F. Localized extremity soft tissue sarcoma: Improved knowledge with unchanged survival over time.J. Clin. Oncol.200321142719272510.1200/JCO.2003.02.02612860950
     [Google Scholar]
  5. (PDQ®): Health Professional Version.PDQ Cancer Information Summaries.Bethesda (MD), USNational Cancer Institute200216
     [Google Scholar]
  6. WangD. HarrisJ. KraybillW.G. EisenbergB. KirschD.G. EttingerD.S. KaneJ.M.III BarryP.N. NaghaviA. FreemanC.R. ChenY.L. HitchcockY.J. BediM. SalernoK.E. SeverinD. GodetteK.D. LarrierN.A. CurranW.J.Jr Torres-SaavedraP.A. LucasD.R. Pathologic complete response and clinical outcomes in patients with localized soft tissue sarcoma treated with neoadjuvant chemoradiotherapy or radiotherapy.JAMA Oncol.20239564665510.1001/jamaoncol.2023.004236995690
     [Google Scholar]
  7. ViallardC. LarrivéeB. Tumor angiogenesis and vascular normalization: Alternative therapeutic targets.Angiogenesis201720440942610.1007/s10456‑017‑9562‑928660302
     [Google Scholar]
  8. MatsumotoS. BatraS. SaitoK. YasuiH. ChoudhuriR. GadisettiC. SubramanianS. DevasahayamN. MunasingheJ.P. MitchellJ.B. KrishnaM.C. Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia.Cancer Res.201171206350635910.1158/0008‑5472.CAN‑11‑202521878530
     [Google Scholar]
  9. GoedegebuureR.S.A. de KlerkL.K. BassA.J. DerksS. ThijssenV.L.J.L. Combining radiotherapy with anti-angiogenic therapy and immunotherapy; a therapeutic triad for cancer?Front. Immunol.20199310710.3389/fimmu.2018.0310730692993
     [Google Scholar]
  10. YangT. XiaoH. LiuX. WangZ. ZhangQ. WeiN. GuoX. Vascular normalization: A new window opened for cancer therapies.Front. Oncol.20211171983610.3389/fonc.2021.71983634476218
     [Google Scholar]
  11. MagnussenA.L. MillsI.G. Vascular normalisation as the stepping stone into tumour microenvironment transformation.Br. J. Cancer2021125332433610.1038/s41416‑021‑01330‑z33828258
     [Google Scholar]
  12. RocchiL. CaraffiS. PerrisR. MangieriD. The angiogenic asset of soft tissue sarcomas: A new tool to discover new therapeutic targets.Biosci. Rep.2014346e0014710.1042/BSR2014007525236925
     [Google Scholar]
  13. HeymachJ.V. Angiogenesis and antiangiogenic approaches to sarcomas.Curr. Opin. Oncol.200113426126910.1097/00001622‑200107000‑0000911429484
     [Google Scholar]
  14. LuganoR. RamachandranM. DimbergA. Tumor angiogenesis: Causes, consequences, challenges and opportunities.Cell. Mol. Life Sci.20207791745177010.1007/s00018‑019‑03351‑731690961
     [Google Scholar]
  15. WadlowR.C. RyanD.P. The role of targeted agents in preoperative chemoradiation for rectal cancer.Cancer2010116153537354810.1002/cncr.2515520564106
     [Google Scholar]
  16. SpigelD.R. BendellJ.C. McCleodM. ShipleyD.L. ArrowsmithE. BarnesE.K. InfanteJ.R. BurrisH.A.III GrecoF.A. HainsworthJ.D. Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.Clin. Colorectal Cancer2012111455210.1016/j.clcc.2011.04.00221840771
     [Google Scholar]
  17. JainR.K. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy.Science20053075706586210.1126/science.110481915637262
     [Google Scholar]
  18. MeyerJ.M. PerlewitzK.S. HaydenJ.B. DoungY.C. HungA.Y. VettoJ.T. PommierR.F. MansoorA. BeckettB.R. TudoricaA. MoriM. HoltorfM.L. AfzalA. WoodwardW.J. RodlerE.T. JonesR.L. HuangW. RyanC.W. Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.Clin. Cancer Res.201319246902691110.1158/1078‑0432.CCR‑13‑159424132922
     [Google Scholar]
  19. CanterR.J. BorysD. OlusanyaA. LiC.S. LeeL.Y. BoutinR.D. ChristensenS.D. TamurianR.M. MonjazebA.M. Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.Ann. Surg. Oncol.20142151616162310.1245/s10434‑014‑3543‑724554062
     [Google Scholar]
  20. DadrasM. KoeppP. WallnerC. WagnerJ.M. SogorskiA. LehnhardtM. HaratiK. BehrB. Wound complications are a predictor of worse oncologic outcome in extremity soft tissue sarcomas.Surg. Oncol.20203312613410.1016/j.suronc.2020.02.01632561077
     [Google Scholar]
  21. PotkrajcicV. KolbenschlagJ. SachsenmaierS. DaigelerA. LadurnerR. GolfA. GaniC. ZipsD. PaulsenF. EckertF. Postoperative complications and oncologic outcomes after multimodal therapy of localized high risk soft tissue sarcoma.Radiat. Oncol.202217121010.1186/s13014‑022‑02166‑436544149
     [Google Scholar]
  22. CallaghanC.M. HasibuzzamanM.M. RodmanS.N. GoetzJ.E. MapuskarK.A. PetronekM.S. SteinbachE.J. MillerB.J. PulliamC.F. ColemanM.C. MongaV.V. MilhemM.M. SpitzD.R. AllenB.G. Neoadjuvant radiotherapy-related wound morbidity in soft tissue sarcoma: Perspectives for radioprotective agents.Cancers (Basel)2020128225810.3390/cancers1208225832806601
     [Google Scholar]
  23. O’SullivanB. DavisA.M. TurcotteR. BellR. CattonC. ChabotP. WunderJ. KandelR. GoddardK. SaduraA. PaterJ. ZeeB. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial.Lancet200235993252235224110.1016/S0140‑6736(02)09292‑912103287
     [Google Scholar]
  24. AlbertsmeierM. RauchA. RoederF. HasenhütlS. PratschkeS. KirschneckM. GronchiA. JebsenN.L. CassierP.A. SargosP. BelkaC. LindnerL.H. WernerJ. AngeleM.K. External beam radiation therapy for resectable soft tissue sarcoma: A systematic review and meta-analysis.Ann. Surg. Oncol.201825375476710.1245/s10434‑017‑6081‑228895107
     [Google Scholar]
  25. LewinJ. KhamlyK.K. YoungR.J. MitchellC. HicksR.J. TonerG.C. NganS.Y.K. ChanderS. PowellG.J. HerschtalA. Te MarveldeL. DesaiJ. ChoongP F M. StackerS.A. AchenM.G. FerrisN. FoxS. SlavinJ. ThomasD.M. A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.Br. J. Cancer2014111122254226110.1038/bjc.2014.53725321190
     [Google Scholar]
  26. HaasR.L.M. GelderblomH. SleijferS. van BovenH.H. ScholtenA. DewitL. BorstG. van der HageJ. KerstJ.M. NoutR.A. HartgrinkH.H. de PreeI. VerhoefC. SteeghsN. van CoevordenF. A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities.Acta Oncol.20155481195120110.3109/0284186X.2015.103740425920360
     [Google Scholar]
  27. JakobJ. SimeonovaA. KasperB. RonellenfitschU. RauchG. WenzF. HohenbergerP. Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: Results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).Radiat. Oncol.20161117710.1186/s13014‑016‑0654‑227255678
     [Google Scholar]
  28. van MeekerenM. BoveeJ.V.M.G. van CoevordenF. van HoudtW. SchrageY. KoenenA.M. MiahA.B. ZaidiS. HayesA.J. ThwayK. KrolS. FioccoM. GelderblomH. SteeghsN. HaasR.L. A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma.Acta Oncol.202160121557156410.1080/0284186X.2021.197129434554030
     [Google Scholar]
  29. KaytonM.L. WeissA.R. XueW. BinitieO. Hayes DixonA. RandallR.L. SorgerJ.I. HawkinsD.S. SpuntS.L. WangD. MillionL. TerezakisS. ChoyE. OkunoS.H. VenkatramaniR. ChenY.L. ScharschmidtT.J. Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children’s Oncology Group and NRG Oncology.J. Surg. Oncol.2023127587188110.1002/jso.2720536779385
     [Google Scholar]
  30. TsengJ.F. BalloM.T. LangsteinH.N. WayneJ.D. CormierJ.N. HuntK.K. FeigB.W. YaskoA.W. LewisV.O. LinP.P. CannonC.P. ZagarsG.K. PollockR.E. PistersP.W.T. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas.Ann. Surg. Oncol.20061391209121510.1245/s10434‑006‑9028‑616952046
     [Google Scholar]
  31. CannonC.P. BalloM.T. ZagarsG.K. MirzaA.N. LinP.P. LewisV.O. YaskoA.W. BenjaminR.S. PistersP.W.T. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas.Cancer2006107102455246110.1002/cncr.2229817036354
     [Google Scholar]
  32. GriffinA.M. DickieC.I. CattonC.N. ChungP.W.M. FergusonP.C. WunderJ.S. O’SullivanB. The influence of time interval between preoperative radiation and surgical resection on the development of wound healing complications in extremity soft tissue sarcoma.Ann. Surg. Oncol.20152292824283010.1245/s10434‑015‑4631‑z26018726
     [Google Scholar]
  33. HoefkensF. DehandschutterC. SomvilleJ. MeijndersP. Van GestelD. Soft tissue sarcoma of the extremities: Pending questions on surgery and radiotherapy.Radiat. Oncol.201611113610.1186/s13014‑016‑0668‑927733179
     [Google Scholar]
  34. von MehrenM. RandallR.L. BenjaminR.S. BolesS. BuiM.M. GanjooK.N. GeorgeS. GonzalezR.J. HeslinM.J. KaneJ.M.III KeedyV. KimE. KoonH. MayersonJ. McCarterM. McGarryS.V. MeyerC. MorrisZ.S. O’DonnellR.J. PappoA.S. PazI.B. PetersenI.A. PfeiferJ.D. RiedelR.F. RuoB. SchuetzeS. TapW.D. WayneJ.D. BergmanM.A. ScavoneJ.L. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology.J. Natl. Compr. Canc. Netw.201816553656310.6004/jnccn.2018.002529752328
     [Google Scholar]
  35. WangD. AbramsR.A. Radiotherapy for soft tissue sarcoma: 50 years of change and improvement.Am. Soc. Clin. Oncol. Educ. Book2014343424425110.14694/EdBook_AM.2014.34.24424857082
     [Google Scholar]
  36. FolkertM.R. SingerS. BrennanM.F. KukD. QinL.X. KobayashiW.K. CragoA.M. AlektiarK.M. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity.J. Clin. Oncol.201432293236324110.1200/JCO.2013.53.945225185087
     [Google Scholar]
  37. SwansonE.L. IndelicatoD.J. LouisD. FlampouriS. LiZ. MorrisC.G. ParyaniN. SlopsemaR. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.Int. J. Radiat. Oncol. Biol. Phys.20128351549155710.1016/j.ijrobp.2011.10.01422270176
     [Google Scholar]
  38. RöperB. HeinrichC. KehlV. RechlH. SpechtK. WörtlerK. TöpferA. MollsM. KampferS. von Eisenharth-RotheR. CombsS.E. Study of preoperative radiotherapy for sarcomas of the extremities with intensity-modulation, image-guidance and small safety-margins (PREMISS).BMC Cancer201515190410.1186/s12885‑015‑1633‑y26573139
     [Google Scholar]
  39. WangD. ZhangQ. EisenbergB.L. KaneJ.M. LiX.A. LucasD. PetersenI.A. DeLaneyT.F. FreemanC.R. FinkelsteinS.E. HitchcockY.J. BediM. SinghA.K. DundasG. KirschD.G. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: Results of radiation therapy oncology group RTOG-0630 trial.J. Clin. Oncol.201533202231223810.1200/JCO.2014.58.582825667281
     [Google Scholar]
  40. O’SullivanB. GriffinA.M. DickieC.I. SharpeM.B. ChungP.W.M. CattonC.N. FergusonP.C. WunderJ.S. DeheshiB.M. WhiteL.M. KandelR.A. JaffrayD.A. BellR.S. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma.Cancer2013119101878188410.1002/cncr.2795123423841
     [Google Scholar]
  41. DavisA. OsullivanB. TurcotteR. BellR. CattonC. ChabotP. WunderJ. HammondA. BenkV. KandelR. GoddardK. FreemanC. SaduraA. ZeeB. DayA. TuD. PaterJ. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma.Radiother. Oncol.2005751485310.1016/j.radonc.2004.12.02015948265
     [Google Scholar]
  42. WhitelawG.L. Blasiak-WalI. CookeK. UsherC. MacDougallN.D. PlowmanP.N. A dosimetric comparison between two intensity-modulated radiotherapy techniques: Tomotherapy vs. dynamic linear accelerator.Br. J. Radiol.20088196433334010.1259/bjr/6708458318344277
     [Google Scholar]
  43. PlowmanP.N. CookeK. WalshN. Indications for tomotherapy/intensity-modulated radiation therapy in paediatric radiotherapy: Extracranial disease.Br. J. Radiol.20088197187288010.1259/bjr/1487899918941047
     [Google Scholar]
  44. BrayF.N. SimmonsB.J. WolfsonA.H. NouriK. Acute and chronic cutaneous reactions to ionizing radiation therapy.Dermatol. Ther. (Heidelb.)20166218520610.1007/s13555‑016‑0120‑y27250839
     [Google Scholar]
  45. CaleyM.P. MartinsV.L.C. O’TooleE.A. Metalloproteinases and wound healing.Adv. Wound Care (New Rochelle)20154422523410.1089/wound.2014.058125945285
     [Google Scholar]
  46. JacobsonL.K. JohnsonM.B. DedhiaR.D. Niknam-BieniaS. WongA.K. Impaired wound healing after radiation therapy: A systematic review of pathogenesis and treatment.JPRAS Open2017139210510.1016/j.jpra.2017.04.001
     [Google Scholar]
  47. HaroonZ.A. RaleighJ.A. GreenbergC.S. DewhirstM.W. Early wound healing exhibits cytokine surge without evidence of hypoxia.Ann. Surg.2000231113714710.1097/00000658‑200001000‑0002010636114
     [Google Scholar]
  48. DelanianS. MartinM. BravardA. LuccioniC. LefaixJ.L. Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage.Radiother. Oncol.199847325526110.1016/S0167‑8140(97)00195‑39681888
     [Google Scholar]
  49. AkitaS. Treatment of radiation injury.Adv. Wound Care (New Rochelle)20143111110.1089/wound.2012.040324761339
     [Google Scholar]
  50. Radiation-Induced Skin Injury: A Challenging Issue in the Outpatient Wound Clinic.2024Available from: https://www.hmpgloballearningnetwork.com/site/twc/articles/radiation-induced-skin-injury-challenging-issue-outpatient-wound-clinic (Accessed on: March 4, 2024).
  51. KraybillW.G. HarrisJ. SpiroI.J. EttingerD.S. DeLaneyT.F. BlumR.H. LucasD.R. HarmonD.C. LetsonG.D. EisenbergB. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.J. Clin. Oncol.200624461962510.1200/JCO.2005.02.557716446334
     [Google Scholar]
  52. KaoY.S. Preoperative ultra-hypofractionation radiotherapy in extremity/trunk wall soft tissue sarcoma — A meta-analysis of prospective studies.Cancer Radiother.20232729610210.1016/j.canrad.2022.07.01436028419
     [Google Scholar]
  53. RoohaniS. EhretF. KobusM. FlörckenA. MärdianS. StrieflerJ.K. RauD. ÖllingerR. JaroschA. BudachV. KaulD. Preoperative hypofractionated radiotherapy for soft tissue sarcomas: A systematic review.Radiat. Oncol.202217115910.1186/s13014‑022‑02072‑936104789
     [Google Scholar]
  54. LeiteE.T.T. MunhozR.R. CamargoV.P. LimaL.G.C.A. RebolledoD.C.S. MaistroC.E.B. BusnardoF.F. FerreiraF.O. SalvajoliJ.V. CarvalhoH.A. Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities.Radiother. Oncol.202116122222910.1016/j.radonc.2021.06.02734171452
     [Google Scholar]
  55. Gobo SilvaM.L. Lopes de MelloC.A. Aguiar JuniorS. D’Almeida CostaF. Stevanato FilhoP.R. Santoro BezerraT. NakagawaS.A. NascimentoA.G. Werneck da CunhaI. Spencer Sobreira BatistaR.M. Nicolau DaherU.R. Da Cruz FormigaM.N. GermanoJ.N. Catin KupperB.E. De Assis PellizzonA.C. LopesA. Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial.Radiother. Oncol.202115916116710.1016/j.radonc.2021.03.03333798613
     [Google Scholar]
  56. Koseła-PaterczykH. TeteryczP. SpałekM. BorkowskaA. ZawadzkaA. WągrodzkiM. Szumera-CiećkiewiczA. MorysińskiT. ŚwitajT. ŁugowskaI. Castaneda-WysockaP. ZdzienickiM. GoryńT. RutkowskiP. Efficacy and safety of hypofractionated preoperative radiotherapy for primary locally advanced soft tissue sarcomas of limbs or trunk wall.Cancers (Basel)20211312298110.3390/cancers1312298134198676
     [Google Scholar]
  57. KalbasiA. KamravaM. ChuF.I. TelescaD. Van DamsR. YangY. RuanD. NelsonS.D. DryS.M. HernandezJ. ChmielowskiB. SinghA.S. BukataS.V. BernthalN.M. SteinbergM.L. WeidhaasJ.B. EilberF.C. A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma.Clin. Cancer Res.20202681829183610.1158/1078‑0432.CCR‑19‑352432054730
     [Google Scholar]
  58. KubicekG.J. LaCoutureT. KadenM. KimT.W. LermanN. KhrizmanP. PatelA. XuQ. LackmanR. Preoperative radiosurgery for soft tissue sarcoma.Am. J. Clin. Oncol.2018411868910.1097/COC.000000000000023626535989
     [Google Scholar]
  59. WunderJ.S. NielsenT.O. MakiR.G. O’SullivanB. AlmanB.A. Opportunities for improving the therapeutic ratio for patients with sarcoma.Lancet Oncol.20078651352410.1016/S1470‑2045(07)70169‑917540303
     [Google Scholar]
  60. FrustaciS. De PaoliA. BidoliE. La MuraN. BerrettaM. BuonadonnaA. BozG. GherlinzoniF. Ifosfamide in the adjuvant therapy of soft tissue sarcomas.Oncology200365Suppl. 2808410.1159/00007336614586155
     [Google Scholar]
  61. PetrioliR. CorattiA. CorrealeP. D’AnielloC. GrimaldiL. TanziniG. CivitelliS. MarsiliS. MessineseS. MarzoccaG. PirtoliL. FranciniG. Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma.Am. J. Clin. Oncol.200225546847310.1097/00000421‑200210000‑0000912393986
     [Google Scholar]
  62. AwadaA. HendliszA. GilT. BartholomeusS. ManoM. de ValeriolaD. StrumbergD. BrendelE. HaaseC.G. SchwartzB. PiccartM. Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours.Br. J. Cancer200592101855186110.1038/sj.bjc.660258415870716
     [Google Scholar]
  63. StrumbergD. RichlyH. HilgerR.A. SchleucherN. KorfeeS. TewesM. FaghihM. BrendelE. VoliotisD. HaaseC.G. SchwartzB. AwadaA. VoigtmannR. ScheulenM.E. SeeberS. Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.J. Clin. Oncol.200523596597210.1200/JCO.2005.06.12415613696
     [Google Scholar]
  64. RatainM.J. EisenT. StadlerW.M. FlahertyK.T. KayeS.B. RosnerG.L. GoreM. DesaiA.A. PatnaikA. XiongH.Q. RowinskyE. AbbruzzeseJ.L. XiaC. SimantovR. SchwartzB. O’DwyerP.J. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.J. Clin. Oncol.200624162505251210.1200/JCO.2005.03.672316636341
     [Google Scholar]
  65. EscudierB. EisenT. StadlerW.M. SzczylikC. OudardS. SiebelsM. NegrierS. ChevreauC. SolskaE. DesaiA.A. RollandF. DemkowT. HutsonT.E. GoreM. FreemanS. SchwartzB. ShanM. SimantovR. BukowskiR.M. Sorafenib in advanced clear-cell renal-cell carcinoma.N. Engl. J. Med.2007356212513410.1056/NEJMoa06065517215530
     [Google Scholar]
  66. van der GraafW.T.A. BlayJ.Y. ChawlaS.P. KimD.W. Bui-NguyenB. CasaliP.G. SchöffskiP. AgliettaM. StaddonA.P. BeppuY. Le CesneA. GelderblomH. JudsonI.R. ArakiN. OualiM. MarreaudS. HodgeR. DewjiM.R. CoensC. DemetriG.D. FletcherC.D. Dei TosA.P. HohenbergerP. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial.Lancet201237998291879188610.1016/S0140‑6736(12)60651‑522595799
     [Google Scholar]
  67. BittermanD.S. Safety and efficacy of combination targeted therapy and radiotherapy.Am. J. Hematol. Oncol.2016121233
     [Google Scholar]
/content/journals/rrct/10.2174/0115748871354960250315170817
Loading
Wound Healing Complications after Neoadjuvant Radiotherapy Combined with Targeted Therapies in Soft Tissue Sarcoma Patients
Rev. Recent Clin. Trials 20, 301 (2025); https://doi.org/10.2174/0115748871354960250315170817
/content/journals/rrct/10.2174/0115748871354960250315170817
/content/journals/rrct/10.2174/0115748871354960250315170817
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): neoadjuvant treatment; radiotherapy; Soft tissue sarcomas; targeted therapy; vascular endothelial growth factor; wound complications

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test